Literature DB >> 3341691

Inhaled pentamidine and hypoglycemia.

J A Karboski, P J Godley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3341691     DOI: 10.7326/0003-4819-108-3-490_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Pneumocystis carinii pneumonia.

Authors:  S Thomas; M O'Doherty; N Bateman
Journal:  BMJ       Date:  1990-01-27

Review 2.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Diabetes mellitus in a patient with AIDS after treatment with pentamidine aerosol.

Authors:  A Fisch; T Prazuck; J E Malkin; O Patey; C Lafaix
Journal:  BMJ       Date:  1990-10-13

Review 4.  Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.

Authors:  J P Monk; P Benfield
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 5.  Pentamidine. A risk-benefit analysis.

Authors:  B Wispelwey; R Pearson
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

6.  Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

Authors:  R F Miller; P Godfrey-Faussett; S J Semple
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

Review 7.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

8.  Chronic pentamidine aerosol prophylaxis does not induce QT prolongation.

Authors:  C Thalhammer; J R Bogner; G Lohmöller
Journal:  Clin Investig       Date:  1993-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.